Psychiatry Investigation
May 1, 2026
Hye-Yoon Park, Minji Bang, Suk Kyoon An
Schizophrenia (SPR) spectrum disorders involve various subjective symptoms, including disruptions in self-awareness, cognitive complaints, and schizotypy. While tools such as the Examination of Anomalous Self-Experience (EASE), Frankfurt Complaint Questionnaire (Frankfurter Beschwerde-Fragebogen, FBF), and Chapman Psychosis Proneness Scales (CPPS) have been employed, research on their...
Psychiatry Investigation
October 15, 2025
Hong-Ci Lin, Chia-Yu Chang, Ching-Huang Lin et al.
1 citation
This case report discusses a 62-year-old male with treatment-resistant bipolar II depression and hypertension. After poor responses to multiple treatments, an add-on esketamine nasal spray (ESK-NS) was introduced in October 2022. Improvement was seen, and the patient's depressive episode was nearly remitted during the maintenance phase. However, recurrence was noted when ESK-NS frequency was...
Psychiatry Investigation
May 25, 2023
Darya Rostam Ahmed
Based on the author’s clinical experience, the aim of this paper is to conceptually analyse the theory of psychological functioning and action mechanisms in the way mindfulness meditation works. Meditation is a method of revealing unconsciousness. It works in a similar way to the inhibitory and excitatory mechanisms of neurones. Block pathogenic thoughts and emotions that reach the unconscious...
Psychiatry Investigation
October 10, 2021
Chia‐ling Yu, Fu-Chi Yang, Szu‐nian Yang et al.
57 citations
Objective To systematically examine the effectiveness and tolerability of psilocybin for treating end-of-life anxiety symptoms.Methods The Medline, Embase, CENTRAL, and PsycINFO databases were searched up to November 25, 2020. We enrolled clinical trials investigating psilocybin for treating end-of-life anxiety symptoms. Meta-analysis was conducted using random-effects model.Results Overall,...